Prescription drug · ANDA
Amlodipine besylate and Olmesartan medoxomil NDC 27241-085
Amlodipine besylate 10 mg/1; Olmesartan medoxomil 20 mg/1 · Tablet · Oral · Ajanta Pharma USA Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 27241-085-03 | 27241008503 | 30 TABLET in 1 BOTTLE (27241-085-03)Marketed from Feb 6, 2017 | |
| 27241-085-09 | 27241008509 | 90 TABLET in 1 BOTTLE (27241-085-09)Marketed from Feb 6, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Amlodipine besylate and Olmesartan medoxomil
- Generic name (nonproprietary)
- amlodipine besylate and olmesartan medoxomil
- Active ingredients
- Amlodipine besylate — 10 mg/1Olmesartan medoxomil — 20 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Ajanta Pharma USA Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207216
- Marketing start
- Listing expires
- Other FDA classes
- Angiotensin 2 Receptor Antagonists (Mechanism)Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Dihydropyridines (Chemical structure)
- Identifiers
- Product ID 27241-085_1c06acbb-7027-4b05-90a0-4f40c039c705SPL ID 1c06acbb-7027-4b05-90a0-4f40c039c705SPL set ID 69fa6293-b10a-4473-ab9b-1bd53f099bddRxCUI 730861, 730866, 730869, 730872UNII 864V2Q084H, 6M97XTV3HDUPC 0327241085031, 0327241083037, 0327241084034, 0327241086038
- Pharmacologic class
- Angiotensin 2 Receptor Blocker; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N427241008503followed by a unit qualifier and the quantityPackage 27241-0085-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Amlodipine and olmesartan medoxomil tablets are indicated for the treatment of hypertension, alone or with other antihypertensive agents, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular (CV) events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with amlodipine and olmesartan medoxomil tablets. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 207216
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Amlodipine besylate and Olmesartan medoxomil | Amlodipine besylate 5 mg/1; Olmesartan medoxomil 40 mg/1 | TabletOral | Ajanta Pharma USA Inc. | 27241-084 |
| Amlodipine besylate and Olmesartan medoxomil | Amlodipine besylate 5 mg/1; Olmesartan medoxomil 20 mg/1 | TabletOral | Ajanta Pharma USA Inc. | 27241-083 |
| Amlodipine besylate and Olmesartan medoxomil | Amlodipine besylate 10 mg/1; Olmesartan medoxomil 40 mg/1 | TabletOral | Ajanta Pharma USA Inc. | 27241-086 |